Drug information for EOVIST

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SOLUTION; INTRAVENOUS 1.8143GM/10ML (181.43MG/ML) Prescription  (Reference Drug) GADOXETATE DISODIUM gadolinium ethoxybenzyl DTPA BAYER HLTHCARE 22090
2011-12-21 Other Important Information from FDA

2011-11-21 Letter

2011-11-21 Label

2010-12-22 Letter

2010-12-20 Label

2009-11-19 Letter

2008-08-19 Review

2008-08-19 Summary Review

2008-07-15 Letter

2008-07-09 Label

Drug Adverse Effects information for EOVIST

Role code Indications Reaction # Reports
PS NUCLEAR MAGNETIC RESONANCE IMAGING HEADACHE 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING INJECTION SITE EXTRAVASATION 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING NAUSEA 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING THROAT IRRITATION 1
PS NUCLEAR MAGNETIC RESONANCE IMAGING VOMITING 1
PS PRODUCT USED FOR UNKNOWN INDICATION NO ADVERSE EVENT 1
PS PRODUCT USED FOR UNKNOWN INDICATION RESPIRATION ABNORMAL 1
Ads by Google